Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-053392
Filing Date
2025-04-11
Accepted
2025-04-11 18:00:07
Documents
2
Period of Report
2025-04-03

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 4314
2 EX-24 amrn-ex24.htm EX-24 10621
  Complete submission text file 0000950170-25-053392.txt   16663
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CARISMA THERAPEUTICS INC. 3675 MARKET STREET, SUITE 200 PHILADELPHIA PA 19104
Business Address
Torok Michael (Reporting) CIK: 0001967237 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21392 | Film No.: 25833809